{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:24:52Z","timestamp":1790641492843,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01008"],"award-info":[{"award-number":["PI19\/01008"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00759"],"award-info":[{"award-number":["PI20\/00759"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII16\/00016"],"award-info":[{"award-number":["CPII16\/00016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI18\/00141"],"award-info":[{"award-number":["FI18\/00141"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2017SGR1206"],"award-info":[{"award-number":["2017SGR1206"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Biomedical Research on Rare Diseases"},{"DOI":"10.13039\/501100003751","name":"Ministerio de Sanidad, Servicios Sociales e Igualdad","doi-asserted-by":"publisher","award":["EC10-137"],"award-info":[{"award-number":["EC10-137"]}],"id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018433","name":"Hesperia Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018433","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ALE-ELA-Espa\u00f1a"},{"name":"CERTIS Obres i Serveis"},{"name":"the Crowd funding Campaign Arnau\u201997"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00401-022-02451-2","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T18:02:45Z","timestamp":1656698565000},"page":"241-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Activating cannabinoid receptor 2 preserves axonal health through GSK-3\u03b2\/NRF2 axis in adrenoleukodystrophy"],"prefix":"10.1007","volume":"144","author":[{"given":"Janani","family":"Parameswaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Goicoechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Planas-Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel Y.","family":"Calingasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Guilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Aso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinald","family":"Pamplona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Portero-Ot\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Casasnovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9606-0600","authenticated-orcid":false,"given":"Aurora","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"2451_CR1","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s00125-010-1894-6","volume":"53","author":"J Agudo","year":"2010","unstructured":"Agudo J, Martin M, Roca C, Molas M, Bura AS et al (2010) Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. Diabetologia 53:2629\u20132640. https:\/\/doi.org\/10.1007\/s00125-010-1894-6","journal-title":"Diabetologia"},{"key":"2451_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-130137","volume":"35","author":"E Aso","year":"2013","unstructured":"Aso E, Juves S, Maldonado R, Ferrer I (2013) CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AbetaPP\/PS1 mice. J Alzheimers Dis 35:847\u2013858. https:\/\/doi.org\/10.3233\/JAD-130137","journal-title":"J Alzheimers Dis"},{"key":"2451_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s13023-021-02040-8","volume":"16","author":"S Attarian","year":"2021","unstructured":"Attarian S, Young P, Brannagan TH, Adams D, Van Damme P et al (2021) A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A. Orphanet J Rare Dis 16:433. https:\/\/doi.org\/10.1186\/s13023-021-02040-8","journal-title":"Orphanet J Rare Dis"},{"key":"2451_CR4","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","volume":"322","author":"P Aubourg","year":"1990","unstructured":"Aubourg P, Blanche S, Jambaque I, Rocchiccioli F, Kalifa G et al (1990) Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860\u20131866. https:\/\/doi.org\/10.1056\/NEJM199006283222607","journal-title":"N Engl J Med"},{"key":"2451_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2015.09.020","volume":"163","author":"AP Bailey","year":"2015","unstructured":"Bailey AP, Koster G, Guillermier C, Hirst EM, MacRae JI et al (2015) Antioxidant Role for lipid droplets in a stem cell niche of drosophila. Cell 163:340\u2013353. https:\/\/doi.org\/10.1016\/j.cell.2015.09.020","journal-title":"Cell"},{"key":"2451_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fcell.2020.00499","volume":"8","author":"RW Barendsen","year":"2020","unstructured":"Barendsen RW, Dijkstra IME, Visser WF, Alders M, Bliek J et al (2020) Adrenoleukodystrophy newborn screening in the netherlands (SCAN Study): the X-factor. Front Cell Dev Biol 8:499. https:\/\/doi.org\/10.3389\/fcell.2020.00499","journal-title":"Front Cell Dev Biol"},{"key":"2451_CR7","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1523\/jneurosci.4814-06.2007","volume":"27","author":"C Benito","year":"2007","unstructured":"Benito C, Romero JP, Tol\u00f3n RM, Clemente D, Docagne F et al (2007) Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27:2396\u20132402. https:\/\/doi.org\/10.1523\/jneurosci.4814-06.2007","journal-title":"J Neurosci"},{"key":"2451_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","volume":"153","author":"C Benito","year":"2008","unstructured":"Benito C, Tol\u00f3n RM, Pazos MR, N\u00fa\u00f1ez E, Castillo AI et al (2008) Cannabinoid CB2 receptors in human brain inflammation. Br J Pharmacol 153:277\u2013285. https:\/\/doi.org\/10.1038\/sj.bjp.0707505","journal-title":"Br J Pharmacol"},{"key":"2451_CR9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/glia.23598","volume":"67","author":"CG Bergner","year":"2019","unstructured":"Bergner CG, van der Meer F, Winkler A, Wrzos C, T\u00fcrkmen M et al (2019) Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy. Glia 67:1196\u20131209. https:\/\/doi.org\/10.1002\/glia.23598","journal-title":"Glia"},{"key":"2451_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/glia.22742","volume":"63","author":"A Bernal-Chico","year":"2015","unstructured":"Bernal-Chico A, Canedo M, Manterola A, Victoria S\u00e1nchez-G\u00f3mez M, P\u00e9rez-Samart\u00edn A et al (2015) Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. Glia 63:163\u2013176. https:\/\/doi.org\/10.1002\/glia.22742","journal-title":"Glia"},{"key":"2451_CR11","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1523\/jneurosci.4008-12.2012","volume":"32","author":"J Bouchard","year":"2012","unstructured":"Bouchard J, Truong J, Bouchard K, Dunkelberger D, Desrayaud S et al (2012) Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington\u2019s disease. J Neurosci 32:18259\u201318268. https:\/\/doi.org\/10.1523\/jneurosci.4008-12.2012","journal-title":"J Neurosci"},{"key":"2451_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M et al (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326:818\u2013823. https:\/\/doi.org\/10.1126\/science.1171242","journal-title":"Science"},{"key":"2451_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-019-00735-2","author":"C Casasnovas","year":"2019","unstructured":"Casasnovas C, Ruiz M, Schluter A, Naudi A, Fourcade S et al (2019) Biomarker identification, safety, and efficacy of high-dose antioxidants for adrenomyeloneuropathy: a phase II Pilot Study. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-019-00735-2","journal-title":"Neurotherapeutics"},{"key":"2451_CR14","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1083\/jcb.201902061","volume":"218","author":"CL Chang","year":"2019","unstructured":"Chang CL, Weigel AV, Ioannou MS, Pasolli HA, Xu CS et al (2019) Spastin tethers lipid droplets to peroxisomes and directs fatty acid trafficking through ESCRT-III. J Cell Biol 218:2583\u20132599. https:\/\/doi.org\/10.1083\/jcb.201902061","journal-title":"J Cell Biol"},{"key":"2451_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.09.008","author":"JF Chmiel","year":"2020","unstructured":"Chmiel JF, Flume P, Downey DG, Dozor AJ, Colombo C et al (2020) Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis. J Cyst Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2020.09.008","journal-title":"J Cyst Fibros"},{"key":"2451_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.100","volume":"48","author":"YC Chung","year":"2016","unstructured":"Chung YC, Shin WH, Baek JY, Cho EJ, Baik HH et al (2016) CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson\u2019s disease. Exp Mol Med 48:e205. https:\/\/doi.org\/10.1038\/emm.2015.100","journal-title":"Exp Mol Med"},{"key":"2451_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.freeradbiomed.2020.01.177","volume":"152","author":"A Coppa","year":"2020","unstructured":"Coppa A, Guha S, Fourcade S, Parameswaran J, Ruiz M et al (2020) The peroxisomal fatty acid transporter ABCD1\/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: a worm model for adrenoleukodystrophy. Free Radic Biol Med 152:797\u2013809. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.01.177","journal-title":"Free Radic Biol Med"},{"key":"2451_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V (2020) Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 16:9\u201329. https:\/\/doi.org\/10.1038\/s41582-019-0284-z","journal-title":"Nat Rev Neurol"},{"key":"2451_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12883-021-02246-0","volume":"21","author":"M D'Hooghe","year":"2021","unstructured":"D\u2019Hooghe M, Willekens B, Delvaux V, D\u2019Haeseleer M, Guillaume D et al (2021) Sativex\u00ae (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience. BMC Neurol 21:227. https:\/\/doi.org\/10.1186\/s12883-021-02246-0","journal-title":"BMC Neurol"},{"key":"2451_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1124\/mol.114.094649","volume":"86","author":"A Dhopeshwarkar","year":"2014","unstructured":"Dhopeshwarkar A, Mackie K (2014) CB2 Cannabinoid receptors as a therapeutic target-what does the future hold? Mol Pharmacol 86:430\u2013437. https:\/\/doi.org\/10.1124\/mol.114.094649","journal-title":"Mol Pharmacol"},{"key":"2451_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd.2018.115","volume":"17","author":"V Di Marzo","year":"2018","unstructured":"Di Marzo V (2018) New approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov 17:623\u2013639. https:\/\/doi.org\/10.1038\/nrd.2018.115","journal-title":"Nat Rev Drug Discov"},{"key":"2451_CR22","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler F, Duncan C, Musolino PL, Orchard PJ, De Oliveira S et al (2017) Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med 377:1630\u20131638. https:\/\/doi.org\/10.1056\/NEJMoa1700554","journal-title":"N Engl J Med"},{"key":"2451_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.21391","volume":"63","author":"FS Eichler","year":"2008","unstructured":"Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S et al (2008) Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol 63:729\u2013742. https:\/\/doi.org\/10.1002\/ana.21391","journal-title":"Ann Neurol"},{"key":"2451_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/21678421.2018.1425454","volume":"19","author":"F Espejo-Porras","year":"2018","unstructured":"Espejo-Porras F, Fern\u00e1ndez-Ruiz J, de Lago E (2018) Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 19:377\u2013386. https:\/\/doi.org\/10.1080\/21678421.2018.1425454","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2451_CR25","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/bph.14216","volume":"176","author":"F Espejo-Porras","year":"2019","unstructured":"Espejo-Porras F, Garc\u00eda-Toscano L, Rodr\u00edguez-Cueto C, Santos-Garc\u00eda I, de Lago E et al (2019) Targeting glial cannabinoid CB(2) receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis. Br J Pharmacol 176:1585\u20131600. https:\/\/doi.org\/10.1111\/bph.14216","journal-title":"Br J Pharmacol"},{"key":"2451_CR26","doi-asserted-by":"publisher","first-page":"8385","DOI":"10.1523\/jneurosci.2900-16.2017","volume":"37","author":"A Feli\u00fa","year":"2017","unstructured":"Feli\u00fa A, Bonilla Del R\u00edo I, Carrillo-Salinas FJ, Hern\u00e1ndez-Torres G, Mestre L et al (2017) 2-Arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination. J Neurosci 37:8385\u20138398. https:\/\/doi.org\/10.1523\/jneurosci.2900-16.2017","journal-title":"J Neurosci"},{"key":"2451_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.722801","volume":"12","author":"O Fernandez","year":"2021","unstructured":"Fernandez O, Costa-Frossard L, Mart\u00ednez-Gin\u00e9s ML, Montero P, Prieto-Gonz\u00e1lez JM et al (2021) Integrated management of multiple sclerosis spasticity and associated symptoms using the spasticity-plus syndrome concept: results of a structured specialists\u2019 discussion using the Workmat(\u00ae) methodology. Front Neurol 12:722801. https:\/\/doi.org\/10.3389\/fneur.2021.722801","journal-title":"Front Neurol"},{"key":"2451_CR28","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1093\/hmg\/ddi384","volume":"14","author":"I Ferrer","year":"2005","unstructured":"Ferrer I, Kapfhammer JP, Hindelang C, Kemp S, Troffer-Charlier N et al (2005) Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. Hum Mol Genet 14:3565\u20133577. https:\/\/doi.org\/10.1093\/hmg\/ddi384","journal-title":"Hum Mol Genet"},{"key":"2451_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2015.05.041","volume":"88","author":"S Fourcade","year":"2015","unstructured":"Fourcade S, Ferrer I, Pujol A (2015) Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: a paradigm for axonal degeneration. Free Radic Biol Med 88:18\u201329. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.05.041","journal-title":"Free Radic Biol Med"},{"key":"2451_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/bpa.12869","volume":"30","author":"S Fourcade","year":"2020","unstructured":"Fourcade S, Goicoechea L, Parameswaran J, Schl\u00fcter A, Launay N et al (2020) High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy. Brain Pathol 30:945\u2013963. https:\/\/doi.org\/10.1111\/bpa.12869","journal-title":"Brain Pathol"},{"key":"2451_CR31","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","volume":"17","author":"S Fourcade","year":"2008","unstructured":"Fourcade S, Lopez-Erauskin J, Galino J, Duval C, Naudi A et al (2008) Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 17:1762\u20131773. https:\/\/doi.org\/10.1093\/hmg\/ddn085","journal-title":"Hum Mol Genet"},{"key":"2451_CR32","doi-asserted-by":"publisher","first-page":"E211","DOI":"10.1152\/ajpendo.90736.2008","volume":"296","author":"S Fourcade","year":"2009","unstructured":"Fourcade S, Ruiz M, Camps C, Schluter A, Houten SM et al (2009) A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab 296:E211-221. https:\/\/doi.org\/10.1152\/ajpendo.90736.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2451_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10571-019-00719-y","volume":"40","author":"M Gal\u00e1n-Ganga","year":"2020","unstructured":"Gal\u00e1n-Ganga M, Del R\u00edo R, Jim\u00e9nez-Moreno N, D\u00edaz-Guerra M, Lastres-Becker I (2020) Cannabinoid CB(2) receptor modulation by the transcription factor NRF2 is specific in microglial cells. Cell Mol Neurobiol 40:167\u2013177. https:\/\/doi.org\/10.1007\/s10571-019-00719-y","journal-title":"Cell Mol Neurobiol"},{"key":"2451_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.bbadis.2012.02.005","volume":"1822","author":"E Galea","year":"2012","unstructured":"Galea E, Launay N, Portero-Otin M, Ruiz M, Pamplona R et al (2012) Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim Biophys Acta 1822:1475\u20131488. https:\/\/doi.org\/10.1016\/j.bbadis.2012.02.005","journal-title":"Biochim Biophys Acta"},{"key":"2451_CR35","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1089\/ars.2010.3877","volume":"15","author":"J Galino","year":"2011","unstructured":"Galino J, Ruiz M, Fourcade S, Schluter A, Lopez-Erauskin J et al (2011) Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal 15:2095\u20132107. https:\/\/doi.org\/10.1089\/ars.2010.3877","journal-title":"Antioxid Redox Signal"},{"key":"2451_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s0140-6736(18)31311-4","volume":"392","author":"J Ghosn","year":"2018","unstructured":"Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C (2018) HIV. Lancet 392:685\u2013697. https:\/\/doi.org\/10.1016\/s0140-6736(18)31311-4","journal-title":"Lancet"},{"key":"2451_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ana.25085","volume":"82","author":"Y Gong","year":"2017","unstructured":"Gong Y, Sasidharan N, Laheji F, Frosch M, Musolino P et al (2017) Microglial dysfunction as a key pathological change in adrenomyeloneuropathy. Ann Neurol 82:813\u2013827. https:\/\/doi.org\/10.1002\/ana.25085","journal-title":"Ann Neurol"},{"key":"2451_CR38","doi-asserted-by":"publisher","first-page":"8224","DOI":"10.1021\/jm4005626","volume":"56","author":"S Han","year":"2013","unstructured":"Han S, Thatte J, Buzard DJ, Jones RM (2013) Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. J Med Chem 56:8224\u20138256. https:\/\/doi.org\/10.1021\/jm4005626","journal-title":"J Med Chem"},{"key":"2451_CR39","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1021\/acsmedchemlett.7b00396","volume":"8","author":"S Han","year":"2017","unstructured":"Han S, Thoresen L, Jung JK, Zhu X, Thatte J et al (2017) Discovery of APD371: identification of a highly potent and selective CB(2) agonist for the treatment of chronic pain. ACS Med Chem Lett 8:1309\u20131313. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00396","journal-title":"ACS Med Chem Lett"},{"key":"2451_CR40","doi-asserted-by":"publisher","first-page":"14924","DOI":"10.1073\/pnas.1413706111","volume":"111","author":"JM Inloes","year":"2014","unstructured":"Inloes JM, Hsu KL, Dix MM, Viader A, Masuda K et al (2014) The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase. Proc Natl Acad Sci USA 111:14924\u201314929. https:\/\/doi.org\/10.1073\/pnas.1413706111","journal-title":"Proc Natl Acad Sci USA"},{"key":"2451_CR41","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1021\/acs.biochem.7b01028","volume":"57","author":"JM Inloes","year":"2018","unstructured":"Inloes JM, Kiosses WB, Wang H, Walther TC, Farese RV Jr et al (2018) Functional contribution of the spastic paraplegia-related triglyceride hydrolase DDHD2 to the formation and content of lipid droplets. Biochemistry 57:827\u2013838. https:\/\/doi.org\/10.1021\/acs.biochem.7b01028","journal-title":"Biochemistry"},{"key":"2451_CR42","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.abf6099","volume":"374","author":"E Keimpema","year":"2021","unstructured":"Keimpema E, Di Marzo V, Harkany T (2021) Biological basis of cannabinoid medicines. Science 374:1449\u20131450. https:\/\/doi.org\/10.1126\/science.abf6099","journal-title":"Science"},{"key":"2451_CR43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrendo.2016.90","volume":"12","author":"S Kemp","year":"2016","unstructured":"Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M (2016) Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol 12:606\u2013615. https:\/\/doi.org\/10.1038\/nrendo.2016.90","journal-title":"Nat Rev Endocrinol"},{"key":"2451_CR44","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.celrep.2013.04.015","volume":"3","author":"RW Klemm","year":"2013","unstructured":"Klemm RW, Norton JP, Cole RA, Li CS, Park SH et al (2013) A conserved role for atlastin GTPases in regulating lipid droplet size. Cell Rep 3:1465\u20131475. https:\/\/doi.org\/10.1016\/j.celrep.2013.04.015","journal-title":"Cell Rep"},{"key":"2451_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2013.11.002","volume":"287","author":"W Kong","year":"2014","unstructured":"Kong W, Li H, Tuma RF, Ganea D (2014) Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Cell Immunol 287:1\u201317. https:\/\/doi.org\/10.1016\/j.cellimm.2013.11.002","journal-title":"Cell Immunol"},{"key":"2451_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0769","volume":"1","author":"JS Kuhl","year":"2018","unstructured":"Kuhl JS, Kupper J, Baque H, Ebell W, Gartner J et al (2018) Potential risks to stable long-term outcome of allogeneic hematopoietic stem cell transplantation for children with cerebral X-linked adrenoleukodystrophy. JAMA Netw Open 1:e180769. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0769","journal-title":"JAMA Netw Open"},{"key":"2451_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-014-1378-8","volume":"129","author":"N Launay","year":"2015","unstructured":"Launay N, Aguado C, Fourcade S, Ruiz M, Grau L et al (2015) Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy. Acta Neuropathol 129:399\u2013415. https:\/\/doi.org\/10.1007\/s00401-014-1378-8","journal-title":"Acta Neuropathol"},{"key":"2451_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00401-016-1655-9","volume":"133","author":"N Launay","year":"2017","unstructured":"Launay N, Ruiz M, Grau L, Ortega FJ, Ilieva EV et al (2017) Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy. Acta Neuropathol 133:283\u2013301. https:\/\/doi.org\/10.1007\/s00401-016-1655-9","journal-title":"Acta Neuropathol"},{"key":"2451_CR49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu L, Zhang K, Sandoval H, Yamamoto S, Jaiswal M et al (2015) Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell 160:177\u2013190. https:\/\/doi.org\/10.1016\/j.cell.2014.12.019","journal-title":"Cell"},{"key":"2451_CR50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ana.22363","volume":"70","author":"J Lopez-Erauskin","year":"2011","unstructured":"Lopez-Erauskin J, Fourcade S, Galino J, Ruiz M, Schluter A et al (2011) Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol 70:84\u201392. https:\/\/doi.org\/10.1002\/ana.22363","journal-title":"Ann Neurol"},{"key":"2451_CR51","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1093\/brain\/aws292","volume":"135","author":"J Lopez-Erauskin","year":"2012","unstructured":"Lopez-Erauskin J, Galino J, Bianchi P, Fourcade S, Andreu AL et al (2012) Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy. Brain 135:3584\u20133598. https:\/\/doi.org\/10.1093\/brain\/aws292","journal-title":"Brain"},{"key":"2451_CR52","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1093\/hmg\/ddt186","volume":"22","author":"J Lopez-Erauskin","year":"2013","unstructured":"Lopez-Erauskin J, Galino J, Ruiz M, Cuezva JM, Fabregat I et al (2013) Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy. Hum Mol Genet 22:3296\u20133305. https:\/\/doi.org\/10.1093\/hmg\/ddt186","journal-title":"Hum Mol Genet"},{"key":"2451_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12974-018-1174-9","volume":"15","author":"A L\u00f3pez","year":"2018","unstructured":"L\u00f3pez A, Aparicio N, Pazos MR, Grande MT, Barreda-Manso MA et al (2018) Cannabinoid CB(2) receptors in the mouse brain: relevance for Alzheimer\u2019s disease. J Neuroinflamm 15:158. https:\/\/doi.org\/10.1186\/s12974-018-1174-9","journal-title":"J Neuroinflamm"},{"key":"2451_CR54","doi-asserted-by":"publisher","first-page":"9366","DOI":"10.1073\/pnas.94.17.9366","volume":"94","author":"JF Lu","year":"1997","unstructured":"Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB et al (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 94:9366\u20139371. https:\/\/doi.org\/10.1073\/pnas.94.17.9366","journal-title":"Proc Natl Acad Sci USA"},{"key":"2451_CR55","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jimd.12356","volume":"44","author":"EJ Mallack","year":"2021","unstructured":"Mallack EJ, Turk BR, Yan H, Price C, Demetres M et al (2021) MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines. J Inherit Metab Dis 44:728\u2013739. https:\/\/doi.org\/10.1002\/jimd.12356","journal-title":"J Inherit Metab Dis"},{"key":"2451_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","volume":"95","author":"K Maresz","year":"2005","unstructured":"Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95:437\u2013445. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03380.x","journal-title":"J Neurochem"},{"key":"2451_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-9-8","volume":"9","author":"AM Mart\u00edn-Moreno","year":"2012","unstructured":"Mart\u00edn-Moreno AM, Brera B, Spuch C, Carro E, Garc\u00eda-Garc\u00eda L et al (2012) Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflamm 9:8. https:\/\/doi.org\/10.1186\/1742-2094-9-8","journal-title":"J Neuroinflamm"},{"key":"2451_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","volume":"166","author":"M Mecha","year":"2016","unstructured":"Mecha M, Carrillo-Salinas FJ, Feli\u00fa A, Mestre L, Guaza C (2016) Microglia activation states and cannabinoid system: therapeutic implications. Pharmacol Ther 166:40\u201355. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.06.011","journal-title":"Pharmacol Ther"},{"key":"2451_CR59","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/17460441.2020.1752178","volume":"15","author":"P Morales","year":"2020","unstructured":"Morales P, Jagerovic N (2020) Novel approaches and current challenges with targeting the endocannabinoid system. Expert Opin Drug Discov 15:917\u2013930. https:\/\/doi.org\/10.1080\/17460441.2020.1752178","journal-title":"Expert Opin Drug Discov"},{"key":"2451_CR60","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/brain\/awt143","volume":"136","author":"L Morato","year":"2013","unstructured":"Morato L, Galino J, Ruiz M, Calingasan NY, Starkov AA et al (2013) Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy. Brain 136:2432\u20132443. https:\/\/doi.org\/10.1093\/brain\/awt143","journal-title":"Brain"},{"key":"2451_CR61","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/cdd.2015.20","volume":"22","author":"L Morato","year":"2015","unstructured":"Morato L, Ruiz M, Boada J, Calingasan NY, Galino J et al (2015) Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy. Cell Death Differ 22:1742\u20131753. https:\/\/doi.org\/10.1038\/cdd.2015.20","journal-title":"Cell Death Differ"},{"key":"2451_CR62","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamaneurol.2018.1585","volume":"75","author":"AB Moser","year":"2018","unstructured":"Moser AB, Fatemi A (2018) Newborn screening and emerging therapies for X-linked adrenoleukodystrophy. JAMA Neurol 75:1175\u20131176. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1585","journal-title":"JAMA Neurol"},{"key":"2451_CR63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13311-018-0603-x","volume":"15","author":"F Navarrete","year":"2018","unstructured":"Navarrete F, Garc\u00eda-Guti\u00e9rrez MS, Aracil-Fern\u00e1ndez A, Lanciego JL, Manzanares J (2018) Cannabinoid CB1 and CB2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson\u2019s disease. Neurotherapeutics 15:459\u2013469. https:\/\/doi.org\/10.1007\/s13311-018-0603-x","journal-title":"Neurotherapeutics"},{"key":"2451_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.nbd.2019.01.014","volume":"125","author":"A Navarro-Romero","year":"2019","unstructured":"Navarro-Romero A, V\u00e1zquez-Oliver A, Gomis-Gonz\u00e1lez M, Garz\u00f3n-Montesinos C, Falc\u00f3n-Moya R et al (2019) Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome. Neurobiol Dis 125:92\u2013106. https:\/\/doi.org\/10.1016\/j.nbd.2019.01.014","journal-title":"Neurobiol Dis"},{"key":"2451_CR65","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/brain\/awp239","volume":"132","author":"J Palazuelos","year":"2009","unstructured":"Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C et al (2009) Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity. Brain 132:3152\u20133164. https:\/\/doi.org\/10.1093\/brain\/awp239","journal-title":"Brain"},{"key":"2451_CR66","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1007\/s10072-020-04413-6","volume":"41","author":"F Patti","year":"2020","unstructured":"Patti F, Chisari CG, Solaro C, Benedetti MD, Berra E et al (2020) Effects of THC\/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study. Neurol Sci 41:2905\u20132913. https:\/\/doi.org\/10.1007\/s10072-020-04413-6","journal-title":"Neurol Sci"},{"key":"2451_CR67","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.devcel.2018.05.002","volume":"45","author":"G Pennetta","year":"2018","unstructured":"Pennetta G, Welte MA (2018) Emerging links between lipid droplets and motor neuron diseases. Dev Cell 45:427\u2013432. https:\/\/doi.org\/10.1016\/j.devcel.2018.05.002","journal-title":"Dev Cell"},{"key":"2451_CR68","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","volume":"13","author":"A Pujol","year":"2004","unstructured":"Pujol A, Ferrer I, Camps C, Metzger E, Hindelang C et al (2004) Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. HumMolGenet 13:2997\u20133006. https:\/\/doi.org\/10.1093\/hmg\/ddh323","journal-title":"HumMolGenet"},{"key":"2451_CR69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","volume":"11","author":"A Pujol","year":"2002","unstructured":"Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M et al (2002) Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 11:499\u2013505. https:\/\/doi.org\/10.1093\/hmg\/11.5.499","journal-title":"Hum Mol Genet"},{"key":"2451_CR70","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708604","author":"P Ranea-Robles","year":"2018","unstructured":"Ranea-Robles P, Launay N, Ruiz M, Calingasan NY, Dumont M et al (2018) Aberrant regulation of the GSK-3beta\/NRF2 axis unveils a novel therapy for adrenoleukodystrophy. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201708604","journal-title":"EMBO Mol Med"},{"key":"2451_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc0555","author":"L Rodr\u00edguez-Pascau","year":"2021","unstructured":"Rodr\u00edguez-Pascau L, Vilalta A, Cerrada M, Traver E, Forss-Petter S et al (2021) The brain penetrant PPAR\u03b3 agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.abc0555","journal-title":"Sci Transl Med"},{"key":"2451_CR72","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1210\/jc.2015-4381","volume":"101","author":"F Rossi","year":"2016","unstructured":"Rossi F, Bellini G, Luongo L, Manzo I, Tolone S et al (2016) Cannabinoid receptor 2 as antiobesity target: inflammation, fat storage, and browning modulation. J Clin Endocrinol Metab 101:3469\u20133478. https:\/\/doi.org\/10.1210\/jc.2015-4381","journal-title":"J Clin Endocrinol Metab"},{"key":"2451_CR73","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.1093\/hmg\/ddv375","volume":"24","author":"M Ruiz","year":"2015","unstructured":"Ruiz M, Jove M, Schluter A, Casasnovas C, Villarroya F et al (2015) Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy. Hum Mol Genet 24:6861\u20136876. https:\/\/doi.org\/10.1093\/hmg\/ddv375","journal-title":"Hum Mol Genet"},{"key":"2451_CR74","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/hmg\/ddr536","volume":"21","author":"A Schluter","year":"2012","unstructured":"Schluter A, Espinosa L, Fourcade S, Galino J, Lopez E et al (2012) Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy. Hum Mol Genet 21:1062\u20131077. https:\/\/doi.org\/10.1093\/hmg\/ddr536","journal-title":"Hum Mol Genet"},{"key":"2451_CR75","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1750-3639.2010.00392.x","volume":"20","author":"I Singh","year":"2010","unstructured":"Singh I, Pujol A (2010) Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol 20:838\u2013844. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00392.x","journal-title":"Brain Pathol"},{"key":"2451_CR76","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/art.41294","volume":"72","author":"R Spiera","year":"2020","unstructured":"Spiera R, Hummers L, Chung L, Frech TM, Domsic R et al (2020) Safety and efficacy of lenabasum in a phase II, randomized, placebo-controlled trial in adults with systemic sclerosis. Arthritis Rheumatol 72:1350\u20131360. https:\/\/doi.org\/10.1002\/art.41294","journal-title":"Arthritis Rheumatol"},{"key":"2451_CR77","first-page":"83","volume":"130","author":"RM Stevens","year":"2019","unstructured":"Stevens RM, Nicholson JR, Sauer A, Nolte T, Corradini L (2019) Evaluation of the selective oral CB2 agonist CNTX-6016 for the treatment of neuropathic pain: pharmacokinetic, efficacy, and safety findings from preclinical studies. PAINWeek Abstract Book 2019. Postgrad Med 130:83\u201384","journal-title":"Postgrad Med"},{"key":"2451_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.673977","volume":"8","author":"N Tadepalle","year":"2021","unstructured":"Tadepalle N, Rugarli EI (2021) Lipid droplets in the pathogenesis of hereditary spastic paraplegia. Front Mol Biosci 8:673977. https:\/\/doi.org\/10.3389\/fmolb.2021.673977","journal-title":"Front Mol Biosci"},{"key":"2451_CR79","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jimd.12044","volume":"42","author":"N Waldhuter","year":"2019","unstructured":"Waldhuter N, Kohler W, Hemmati PG, Jehn C, Peceny R et al (2019) Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophy. J Inherit Metab Dis 42:313\u2013324. https:\/\/doi.org\/10.1002\/jimd.12044","journal-title":"J Inherit Metab Dis"},{"key":"2451_CR80","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/TACG.S49590","volume":"8","author":"C Wiesinger","year":"2015","unstructured":"Wiesinger C, Eichler FS, Berger J (2015) The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet 8:109\u2013121. https:\/\/doi.org\/10.2147\/TACG.S49590","journal-title":"Appl Clin Genet"},{"key":"2451_CR81","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.2337\/db11-1716","volume":"61","author":"J Xu","year":"2012","unstructured":"Xu J, Kulkarni SR, Donepudi AC, More VR, Slitt AL (2012) Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice. Diabetes 61:3208\u20133218. https:\/\/doi.org\/10.2337\/db11-1716","journal-title":"Diabetes"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-022-02451-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-022-02451-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-022-02451-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T10:18:37Z","timestamp":1657966717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-022-02451-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2451"],"URL":"https:\/\/doi.org\/10.1007\/s00401-022-02451-2","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that this article was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}